by Jessica Etheridge | Aug 27, 2024 | Company Details, News and Events
August 26, 2024 | Tom Ballard It’s been a whirlwind year for New Day Diagnostics While seeing its cancer diagnostic work to fruition, the future is becoming a national leader in clinical trial management along with contract research. The last 12 months or so for the...
by Jessica Etheridge | Apr 8, 2024 | News and Events
From Knoxville News Sentinel By Daniel Dasso A Knoxville company has launched a blood test locally that could reshape how patients get one of the more unpleasant but essential medical tests: screening for colorectal cancer. The test, called ColoHealth, is for patients...
by Jessica Etheridge | Mar 28, 2024 | News and Events
Download Episode As Colorectal Cancer Awareness Month 2024 comes to a close, Further Together host Michael Holtz, a 12-year survivor of stage IIIB colorectal cancer, talks to Eric Mayer and Jessica Etheridge, CEO and director of marketing and branding, respectively,...
by Jessica Etheridge | Mar 28, 2024 | News and Events
From Living East Tennessee KNOXVILLE, Tenn. (WATE) — March is National Colorectal Cancer Awareness Month and one group is bringing awareness to the significant development of a blood-test for colorectal cancer. This test is the first of its kind and will offer...
by Jessica Etheridge | Jan 3, 2024 | News and Events
From: Teknovation Author: Tom Ballard The long-term vision involves everything from R&D to commercialization with testing at the heart of the services the company will provide. The new year brings exciting new opportunities for New Day Diagnostics...
by Jessica Etheridge | Sep 14, 2023 | Company Details, News and Events
KNOXVILLE, Tenn., September 14, 2023–New Day Diagnostics is pleased to announce that the Extraordinary General Meeting of Epigenomics AG (Frankfurt General Standard: ECX1), a molecular diagnostics company focused on blood testing for the early detection of...
